Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-04

Clinical Trial Update: Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating hyoscine butylbromide for managing abdominal pain in patients with acute gastroenteritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyoscine Butylbromide (hyoscine butylbromide)

Snippet

Sponsor: Ankara City Hospital Bilkent | Conditions: Acute Gastroenteritis, Abdominal Pain | Phase 4 | Status: COMPLETED